<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05160454</url>
  </required_header>
  <id_info>
    <org_study_id>16NC24</org_study_id>
    <nct_id>NCT05160454</nct_id>
  </id_info>
  <brief_title>NIRS to Evaluate Haemodynamic Reserve in Paediatric Moyamoya</brief_title>
  <acronym>NIRS moyamoya</acronym>
  <official_title>NIRS to Evaluate Haemodynamic Reserve in Paediatric Moyamoya</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Great Ormond Street Hospital for Children NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Great Ormond Street Hospital for Children NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Near infrared spectroscpy is a validated method of evaluating cerebral blood flow. The aim in&#xD;
      this pilot study to explore its use in children with moyamoya disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Moyamoya disease is a cerebrovascular condition in which there is chronic brain&#xD;
      hypoperfusion. As surgery can possibly augment brain blood flow, a method for evalutaing&#xD;
      cerebrovascualr reserve would be helpful in selecting patients for intervention.&#xD;
&#xD;
      Near infrared spectroscopy (NIRS) is a validated non-invasive method of evaluating cerebral&#xD;
      blood flow. We aim to investigate the feasibility and tolerability of using NIRS haemodynamic&#xD;
      reserve in children with moyamoya and controls by evaluating cerebral blood flow in the&#xD;
      baseline state and after breath-holding.&#xD;
&#xD;
      Feasibility will be assessed by how many successful studies are carried out. Tolerability&#xD;
      will be assessed by asking children some simple questions about their experience.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    COVID19&#xD;
  </why_stopped>
  <start_date type="Actual">February 14, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>patients and controls</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of NIRS studies that can be completed in moyamoya patients</measure>
    <time_frame>2years</time_frame>
    <description>how many studies can be completed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient questionnaire to evaluate children's experience of NIRS in moyamoya</measure>
    <time_frame>2years</time_frame>
    <description>ask children re their experience</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Moyamoya</condition>
  <arm_group>
    <arm_group_label>patient</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>child with moyamoya</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>unaffected control</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>near infrared spectroscopy</intervention_name>
    <description>evaluate cerebral blood flow with and without breatholding</description>
    <arm_group_label>control</arm_group_label>
    <arm_group_label>patient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Patients with moyamoya and unaffected healthy controls -&#xD;
&#xD;
        Exclusion Criteria: age &lt;6&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Great Ormond Street Hospital for Children NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>WC1N 3JH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 8, 2019</study_first_submitted>
  <study_first_submitted_qc>December 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2021</study_first_posted>
  <last_update_submitted>December 2, 2021</last_update_submitted>
  <last_update_submitted_qc>December 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Moyamoya Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

